Boston Scientific Corp. (BSX)
91.75
-0.95
(-1.02%)
USD |
NYSE |
Dec 11, 16:00
91.82
+0.07
(+0.08%)
After-Hours: 18:34
Boston Scientific Cash from Investing (Quarterly): -502.00M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Abbott Laboratories | -457.00M |
| Intuitive Surgical, Inc. | 401.00M |
| West Pharmaceutical Services, Inc. | -63.30M |
| Elutia, Inc. | -0.63M |
| Globus Medical, Inc. | -75.84M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 1.343B |
| Cash from Financing (Quarterly) | -104.00M |
| Free Cash Flow | 3.824B |
| Free Cash Flow Per Share (Quarterly) | 0.777 |
| Free Cash Flow to Equity (Quarterly) | 1.144B |
| Free Cash Flow to Firm (Quarterly) | 1.239B |
| Free Cash Flow Yield | 2.79% |